These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
395 related items for PubMed ID: 26231083
1. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation. Ikutomi M, Sahara M, Nakajima T, Minami Y, Morita T, Hirata Y, Komuro I, Nakamura F, Sata M. J Mol Cell Cardiol; 2015 Sep; 86():121-35. PubMed ID: 26231083 [Abstract] [Full Text] [Related]
3. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, Stewart DJ. Circ Res; 2005 Mar 04; 96(4):442-50. PubMed ID: 15692087 [Abstract] [Full Text] [Related]
4. Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension. YanYun P, Wang S, Yang J, Chen B, Sun Z, Ye L, Zhu J, Wang X. Cell Physiol Biochem; 2015 Mar 04; 36(2):683-96. PubMed ID: 25998782 [Abstract] [Full Text] [Related]
5. Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence. Minami Y, Nakajima T, Ikutomi M, Morita T, Komuro I, Sata M, Sahara M. Int J Cardiol; 2015 Mar 04; 186():305-14. PubMed ID: 25838182 [Abstract] [Full Text] [Related]
7. Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells. Liu NM, Siu KL, Youn JY, Cai H. J Mol Med (Berl); 2017 Mar 04; 95(3):335-348. PubMed ID: 28004124 [Abstract] [Full Text] [Related]
10. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice. Aliotta JM, Pereira M, Amaral A, Sorokina A, Igbinoba Z, Hasslinger A, El-Bizri R, Rounds SI, Quesenberry PJ, Klinger JR. Cardiovasc Res; 2013 Dec 01; 100(3):354-62. PubMed ID: 23867631 [Abstract] [Full Text] [Related]
11. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats. Ahmed LA, Rizk SM, El-Maraghy SA. Biochem Pharmacol; 2017 Aug 15; 138():193-204. PubMed ID: 28450224 [Abstract] [Full Text] [Related]
13. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N, Hino J, Harada-Shiba M, Okumura H, Tabata Y, Mochizuki N, Chiba Y, Nishioka K, Miyatake K, Asahara T, Hara H, Mori H. Circulation; 2003 Aug 19; 108(7):889-95. PubMed ID: 12835224 [Abstract] [Full Text] [Related]
16. A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia. Xu RW, Zhang WJ, Zhang JB, Wen JY, Wang M, Liu HL, Pan L, Yu CA, Lou JN, Liu P. Chin Med J (Engl); 2015 Dec 20; 128(24):3357-62. PubMed ID: 26668152 [Abstract] [Full Text] [Related]
17. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation. Cui B, Huang L, Fang Y, Guo R, Yin Y, Zhao X. Microvasc Res; 2011 Jan 20; 81(1):143-50. PubMed ID: 20888843 [Abstract] [Full Text] [Related]